Abstract
Life sciences industry is witnessing a paradigm shift of evidence-based approach from population to patient level. This shift is being supported by structured evidence generation methodologies like Systematic Literature Review (SLR), Real World Evidence (RWE), and others to support regulatory, clinical and policy level decision making. The amalgamation of SLR, with real world data and quantitative techniques like Meta-Analysis, Network Meta-Analysis represent highest level of evidence generation. However, the current state of generating SLR, involves manual and labor-intensive process with high dependency on developed countries. The various stakeholders worldwide viz: researchers and policy makers are demanding technology levers to optimize the end-to-end SLR process. As the future of evidence generation will be more complex, industry should invest in smart, intelligent, and connected technology and science-based ecosystem to disrupt and transform existing manual process. This article presents the SLR trends, challenges and potential transformation use case leveraging technology, global capability, and capacity harmonization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Systematic Literature Review and Meta-Analysis Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
